PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40727493,"Impact, Trends, and Visibility of Scientific Publications on Neurological Effects of COVID-19 Vaccine: A Scientometric Analysis.",2025,Ana Paula Sangama Ramírez; Raúl Sebastián Tello Cavero; Frank Mayta-Tovalino,"Department of Academic, Faculty of Human Medicine, Universidad Científica del Sur, Lima, Perú.; Department of Academic, Faculty of Human Medicine, Universidad Científica del Sur, Lima, Perú.; Department of Academic, Bibliometrics, Evidence Evaluation and Systematic Reviews Group, Human Medicine Faculty, Universidad Científica del Sur, Lima, Perú.",Not found
40727315,"Physician Practices, Attitudes, and Challenges Related to Pediatric COVID-19 Vaccination in the United States.",2025,Yoonjae Kang; Fan Zhang; Tara M Vogt,"Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.",Not found
40727039,A plant secretory sequence enhances immunogenicity of electroporated COVID-19 DNA vaccines.,2025,Olivia Costantina Demurtas; Flavia Novelli; Doriana Triggiani; Caterina Merla; Emanuela Pasquali; Silvia Massa; Rosella Franconi; Claudio Pioli,"Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Sustainable Agrofood Systems (SSPT-AGROS), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.; Energy and Sustainable Economic Development, Division of Biotechnologies (SSPT-BIOTEC), ENEA, Italian National Agency for New Technologies, Rome, Italy.",Not found
40727012,"Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.",2025,Alexander Rumyantsev; Lixia Wang; Shixia Wang; Tracy Kemp; Alana Wriggins; Amy Burks; Danielle Fisher; Katie Brokke; Amy Fix; Susan Hensley; Maggie Lewis; Ray Zhu; Kate Wang; Carolyn Shasha; Giulia Piccini; Alessandro Manenti; Emanuele Montomoli; Rodrigo DeAntonio; Xavier Saez-Llorens; Milagros Chan; Edison Alberto; Gray Heppner; Ulo Palm; Thomas P Monath,"Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; AvanSight, Inc., CA, USA.; AvanSight, Inc., CA, USA.; AvanSight, Inc., CA, USA.; VisMederi srl, Siena, Italy.; VisMederi srl, Siena, Italy.; VisMederi srl, Siena, Italy.; Cevaxin, Panama City, Panama.; Cevaxin, Panama City, Panama.; Cevaxin, Panama City, Panama.; Health Index Multispecialty Clinic, Bacoor, Philippines.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.; Vaxxinity, Inc., FL, USA.",Not found
40726702,Evaluation of the impact of COVID-19 pandemic on the quality of life among the Kuwaiti population - A cross-sectional study.,2025,Mahmood A Alawainati,"Department of Family Medicine, Primary Healthcare Centers, Manama, Bahrain.",Not found
40726698,Assessing breakthrough infections: Covishield (late schedule) versus Covaxin - A prospective comparative analysis in the general population.,2025,Nikita Sharma; Nishu Gupta; Kapil Goel; Rahul Gupta,"Department of Community and Family Medicine, AIIMS, Bilaspur, Himachal Pradesh, India.; Department of Health and Family Welfare, Government of Punjab, India.; Department of Community Medicine and SPH, PGIMER, Chandigarh, India.; Public Health Specialist, Public Health Foundation of India, Gurugram, Haryana, India.",Not found
40726658,"Comment on ""Parents' Views on Pediatric COVID-19 Vaccine in Saudi Arabia"".",2025,Hinpetch Daungsupawong,"Private Academic Consultant, Phonhong, Lao People's Democratic Republic.",Not found
40723723,Revisiting Public Trust and Media Influence During COVID-19 Post-Vaccination Era-Waning of Anxiety and Depression Levels Among Skilled Workers and Students in Serbia.,2025,Snezana Svetozarevic,"National Centre for Corporate Education, 11000 Belgrade, Serbia.",Not found
40722625,Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers.,2025,,,Not found
40721468,Location allocation approach based on influence of points of dispensing.,2025,,,nayyadahalghanmi@stu.kau.edu.sa.
